He has also raised over $ 20 million in venture capital for several
successful biotechnology companies.
Scholar Rock is led by a highly - experienced management team of leaders who have built
successful biotechnology companies, and is backed by leading investors.
As in
the successful biotechnology companies and leading academic research groups, Trends in Biotechnology reflects the view that biotechnology is the integrated use of many biological technologies — from molecular genetics to biochemical engineering.
Thanks to a personal connection, one of the most
successful biotechnology companies in the United States is apparently the new title sponsor of the Science Talent Search (STS), the prestigious high school science competitions run by the Society for Science and the Public (SSP) in Washington, D.C. New York - based Regeneron Pharmaceuticals Inc. will invest $ 100 million over the next 10 years to become the third such sponsor in STS's nearly 75 - year - long history, according to several media outlets.
Not exact matches
Founded in 1994, Exelixis, Inc. (NASDAQ: EXEL) is a commercially
successful, oncology - focused
biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult - to - treat cancers.
IDEAYA Biosciences, Inc., an oncology - focused
biotechnology company committed to the discovery of breakthrough synthetic lethality medicines and immuno - oncology therapies, announced today the
successful completion of a $ 94 million crossover Series B financing.
«If you put humans as the target, even though you are not going to make a human baby, it will be provocative, it will be misinterpreted, but people will engage,» says Andrew Hessel, a self - described futurist and
biotechnology catalyst at Autodesk in San Francisco, California, a
successful software
company that specializes in 3D design programs for architecture and other fields that has been exploring synthetic biology applications in recent years.
«We have a more than century - old tradition of generating
successful pharmaceutical
companies and conducting clinical trials, and a decade of experience in creating
biotechnology companies,» says Ole Frijs - Madsen, Director of Invest in Denmark (IDK).
Whether it is a time of boom or bust, the key to the survival of pharmaceutical and
biotechnology companies is to place
successful products on the marketplace.
Genentech is the oldest
biotechnology company, and it is one of the largest and most
successful.